P

Assignee

RECEPTOS LLC

US15 patents

Top patents by PatentIndex Score

US11117876B2Sep 14, 2021

Crystalline form of ozanimod hydrochloride, and processes for preparation thereof

RECEPTOS LLC2 citations71
US10882830B2Jan 5, 2021

Crystal form of ozanimod hydrochloride and processes for preparation therefor

RECEPTOS LLC2 citations71
US11040954B1Jun 22, 2021

CXCR3 receptor agonists

RECEPTOS LLC2 citations62
US11897848B2Feb 13, 2024

Crystalline forms of ozanimod and processes for preparation thereof

RECEPTOS LLC0 citations61
US11680050B2Jun 20, 2023

Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof

RECEPTOS LLC0 citations61
US11111223B2Sep 7, 2021

Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof

RECEPTOS LLC1 citations61
US11028060B2Jun 8, 2021

Crystalline forms of ozanimod and processes for preparation thereof

RECEPTOS LLC1 citations61
US11066395B2Jul 20, 2021

Dimethylaminoethanol salt of a GLP-1 receptor modulator

RECEPTOS LLC0 citations57
US11278526B2Mar 22, 2022

Compounds and methods for treating lupus

RECEPTOS LLC0 citations54
US12428386B2Sep 30, 2025

Sphingosine 1 phosphate receptor modulators

RECEPTOS LLC0 citations52
US12421199B2Sep 23, 2025

Sphingosine 1 phosphate receptor modulators

RECEPTOS LLC0 citations52
US12364686B2Jul 22, 2025

Sphingosine 1 phosphate receptor modulators

RECEPTOS LLC0 citations52
US11964005B2Apr 23, 2024

Methods of treating atopic dermatitis

RECEPTOS LLC0 citations50
US11207301B2Dec 28, 2021

Sphingosine 1 phosphate receptor agonists for neuroprotection

RECEPTOS LLC0 citations48
US11530205B2Dec 20, 2022

GLP-1 receptor modulators

RECEPTOS LLC0 citations42